Trexquant Investment’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11M Buy
509,949
+215,652
+73% +$4.65M 0.12% 217
2025
Q1
$4.89M Sell
294,297
-138,858
-32% -$2.31M 0.06% 513
2024
Q4
$7.95M Buy
433,155
+49,166
+13% +$902K 0.09% 347
2024
Q3
$5.91M Buy
383,989
+82,311
+27% +$1.27M 0.07% 411
2024
Q2
$4.9M Sell
301,678
-37,833
-11% -$615K 0.07% 408
2024
Q1
$6.28M Buy
339,511
+297,367
+706% +$5.5M 0.13% 232
2023
Q4
$1.32M Buy
+42,144
New +$1.32M 0.03% 719
2023
Q3
Sell
-157,084
Closed -$3.76M 1412
2023
Q2
$3.76M Buy
157,084
+47,887
+44% +$1.15M 0.1% 284
2023
Q1
$2.06M Buy
109,197
+8,409
+8% +$158K 0.06% 449
2022
Q4
$1.6M Buy
100,788
+53,208
+112% +$847K 0.05% 490
2022
Q3
$778K Buy
+47,580
New +$778K 0.03% 625
2022
Q2
Sell
-98,612
Closed -$2.39M 1469
2022
Q1
$2.39M Buy
+98,612
New +$2.39M 0.11% 219
2021
Q4
Sell
-23,902
Closed -$397K 1258
2021
Q3
$397K Sell
23,902
-15,732
-40% -$261K 0.03% 630
2021
Q2
$967K Buy
+39,634
New +$967K 0.08% 318
2021
Q1
Sell
-23,797
Closed -$1.27M 1078
2020
Q4
$1.27M Buy
23,797
+5,552
+30% +$297K 0.13% 205
2020
Q3
$753K Buy
18,245
+3,077
+20% +$127K 0.05% 521
2020
Q2
$735K Sell
15,168
-2,528
-14% -$123K 0.05% 517
2020
Q1
$748K Sell
17,696
-74,645
-81% -$3.16M 0.05% 507
2019
Q4
$3.95M Buy
92,341
+67,844
+277% +$2.9M 0.23% 137
2019
Q3
$882K Buy
24,497
+741
+3% +$26.7K 0.08% 315
2019
Q2
$635K Sell
23,756
-6,481
-21% -$173K 0.06% 416
2019
Q1
$812K Sell
30,237
-10,522
-26% -$283K 0.06% 451
2018
Q4
$659K Buy
+40,759
New +$659K 0.04% 543
2018
Q3
Sell
-28,281
Closed -$432K 915
2018
Q2
$432K Sell
28,281
-23,649
-46% -$361K 0.03% 581
2018
Q1
$1.17M Buy
+51,930
New +$1.17M 0.08% 372